Concepedia

Stephen W. Janning

SW

Statistics

Publications

8

Citations

165

H-Index

8

Active since

1993

Affiliations

GlaxoSmithKline (United States)(Current)

Duke Medical Center

Research Triangle Park Foundation

Stephen W. Janning is an author at GlaxoSmithKline (United States) specializing in medicine, renal pathology, and renal disease.

Top concepts

Publications per year

1993–2018

8

Publications

8

Epidemiology of opioid pharmacy claims in the United States

Rachel E. Williams, MBBS Linda Kalilani, John I. Wurzelmann et al. · Journal of Opioid Management · 2018 · 34 citations

Excessive Use of Vancomycin: A Successful Intervention Strategy at an Academic Medical Center

Carol Hamilton, Richard H. Drew, Stephen W. Janning et al. · Infection Control and Hospital Epidemiology · 2000 · 30 citations

Trimethoprim‐Sulfamethoxazole Pharmacokinetics in Trauma Patients

Mary M. Hess, Bradley A. Boucher, S. Casey Laizure et al. · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 1993 · 22 citations

Enhancing enrollment in palliative care trials: key insights from a randomized, placebo-controlled study.

Amy P. Abernethy, David C. Currow, John I. Wurzelmann et al. · PubMed · 2010 · 21 citations

, , +24

Comparative persistence and adherence to overactive bladder medications in patients with and without diabetes

Stephen S. Johnston, Stephen W. Janning, Gabriel P. Haas et al. · International Journal of Clinical Practice · 2012 · 20 citations

1–5 of 8